Unsurprisingly, four out of ten adults experience regular poor sleep. We all know the consequences of a bad night’s rest…
If you explore the world of the share market for more than two minutes you’re bound to come across the…
I’m not sure what’s harder- wrapping your head around what Archer Material’s (ASX: AXE) does, or comprehending the value of…
Jennie Young was one of the first patients to receive Veyonda, Noxopharm’s (ASX: NOX) proprietary drug. Administered on compassionate grounds,…
Colorectal cancer is the third most commonly occurring cancer in men, and the second in women. Yet every year 130…
From dental devices to jet engines, 3D printing is quickly becoming mainstream. Its use is moving well beyond prototyping and…